Indeed in estrogen receptor-positive breast and endometrial cancers, estradiol acts as a powerful growth factor that supports tumor growth; estrogen activity through different and complex mechanisms may promote tumor development and progression. This evidence concerns the gene ESR1 and neoplasm.